PACB Pacific Biosciences of California, Inc.
Stable Earnings Power
F 19.0 / 100 pillar composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 19.0 pillar composite — hard gates always win.

Profitability

Weight: 20%
F 0
  • 5yr Avg ROIC -23.5%
  • Operating Margin Trend -44.30 pp/yr

Capital Efficiency

Weight: 15%
F 0
  • 5yr Avg ROE -2079.6%
  • 5yr Share-Count CAGR 11.4%

Growth Quality

Weight: 15%
A- 82
  • 5yr Revenue CAGR 15.2%
  • Revenue-Growth Years (5) 3/5

Cash Generation

Weight: 15%
F 0
  • 5yr FCF Margin -130.9%
  • 5yr FCF/NI Conversion 0.00x

Balance Sheet

Weight: 20%
F 0
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) -77.52x
  • Altman Z-Score -6.08

Stability

Weight: 15%
C- 46
  • Negative-Revenue Years (5) 2/5
  • Piotroski F-Score 3

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

0 of 2 gurus held; 3 full exits.

Holders
0 -2
Avg Δ position
New buys
0
Full exits
3
As of Q2 2026